BIS icon

ProShares UltraShort NASDAQ Biotechnology

6 hedge funds and large institutions have $1.26M invested in ProShares UltraShort NASDAQ Biotechnology in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
IMC Chicago
1
IMC Chicago
Illinois
$495K 27,459 +13,256 +93%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$388K 21,506 -13,110 -38%
TRCT
3
Tower Research Capital (TRC)
New York
$317K 17,585 +12,283 +232%
UBS Group
4
UBS Group
Switzerland
$55K 3,026 +1,607 +113%
Morgan Stanley
5
Morgan Stanley
New York
$3K 181 +181 New
Citigroup
6
Citigroup
New York
$2K 85
OMC
7
Old Mission Capital
Illinois
-30,214 Closed
Osaic Holdings
8
Osaic Holdings
Arizona
-1,098 Closed
IA
9
IFP Advisors
Florida
CFGS
10
Concourse Financial Group Securities
Alabama